| scholarly article | Q13442814 |
| P50 | author | Joshua P Nixon | Q57334695 |
| P2093 | author name string | Charles J Billington | |
| Tammy A Butterick | |||
| Catherine M Kotz | |||
| P2860 | cites work | Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q24315738 |
| The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity | Q24317782 | ||
| PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia | Q24604133 | ||
| The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives | Q24622846 | ||
| Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716 | Q28190374 | ||
| PGC-1alpha: a key regulator of energy metabolism | Q28274239 | ||
| Orexins in the regulation of the hypothalamic-pituitary-adrenal axis | Q28299650 | ||
| Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins | Q28576022 | ||
| Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators | Q29617353 | ||
| Neurons containing hypocretin (orexin) project to multiple neuronal systems | Q29619641 | ||
| The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. | Q30883818 | ||
| High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides | Q30992148 | ||
| Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats | Q33854221 | ||
| The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism | Q33945163 | ||
| Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity | Q34072882 | ||
| Dietary obesity in rats: Body weight and body fat accretion in seven strains of rats | Q34234079 | ||
| Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions | Q34385884 | ||
| Interindividual variation in posture allocation: possible role in human obesity | Q34389514 | ||
| Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation | Q34390790 | ||
| Monogenic human obesity syndromes | Q48459623 | ||
| Orexin A mediation of time spent moving in rats: neural mechanisms. | Q48483236 | ||
| Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats | Q48504723 | ||
| Differential expression of orexin receptors 1 and 2 in the rat brain | Q48693654 | ||
| Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats | Q48765244 | ||
| Obesity-prone and -resistant rats differ in their brain [3H]paraminoclonidine binding | Q49052107 | ||
| OX1 orexin receptors activate extracellular signal-regulated kinase in Chinese hamster ovary cells via multiple mechanisms: the role of Ca2+ influx in OX1 receptor signaling. | Q51814196 | ||
| Physical activity reduces the influence of genetic effects on BMI and waist circumference: a study in young adult twins. | Q51861344 | ||
| Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. | Q53614203 | ||
| Reduced norepinephrine turnover in organs and brains of obesity-prone rats. | Q54180527 | ||
| Role of nonexercise activity thermogenesis in resistance to fat gain in humans. | Q55068194 | ||
| Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo? | Q61835088 | ||
| Glucose-induced norepinephrine levels and obesity resistance | Q68186320 | ||
| The response to long-term overfeeding in identical twins | Q68776753 | ||
| Energy expenditure of nonexercise activity | Q73256027 | ||
| Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats | Q73258934 | ||
| Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord | Q73500580 | ||
| Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats | Q73645282 | ||
| Feeding and activity induced by orexin A in the lateral hypothalamus in rats | Q77601391 | ||
| Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat | Q83217742 | ||
| Orexin A in the nucleus accumbens stimulates feeding and locomotor activity | Q34429070 | ||
| Non-exercise activity thermogenesis (NEAT). | Q34529581 | ||
| PGC-1 coactivators in the control of energy metabolism | Q34712077 | ||
| Hypocretins/orexins as integrators of physiological information: lessons from mutant animals | Q34930393 | ||
| Regulation of neuron mitochondrial biogenesis and relevance to brain health | Q34997535 | ||
| Orexins and their receptors: structural aspects and role in peripheral tissues. | Q35076350 | ||
| Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation | Q35129455 | ||
| Spontaneous physical activity protects against fat mass gain. | Q35184774 | ||
| A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents | Q35878433 | ||
| PGC-1alpha: turbocharging mitochondria | Q35904070 | ||
| Chemistry and biology of orexin signaling | Q36047054 | ||
| The neurohormone orexin stimulates hypoxia-inducible factor-1 activity | Q36103662 | ||
| Brain orexin promotes obesity resistance. | Q36297727 | ||
| Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity | Q36312461 | ||
| Orexins: neuropeptides for all seasons and functions | Q36495014 | ||
| Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways | Q36510743 | ||
| Integration of feeding and spontaneous physical activity: role for orexin | Q36513380 | ||
| Neuropeptides controlling energy balance: orexins and neuromedins | Q36531499 | ||
| High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats | Q36724539 | ||
| Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease | Q36935040 | ||
| Neuroregulation of nonexercise activity thermogenesis and obesity resistance | Q37045418 | ||
| Monogenic human obesity | Q37071432 | ||
| Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity | Q37071459 | ||
| PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells | Q37076957 | ||
| Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system | Q37528836 | ||
| Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats | Q38354122 | ||
| Orexin A decreases lipid peroxidation and apoptosis in a novel hypothalamic cell model | Q39314608 | ||
| The signalling profile of recombinant human orexin-2 receptor | Q39965527 | ||
| MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice | Q41881288 | ||
| Dysregulation of hypothalamic serotonin turnover in diet-induced obese rats | Q43894905 | ||
| Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats | Q44680757 | ||
| Cardiovascular risk factors emerge after artificial selection for low aerobic capacity | Q45232068 | ||
| Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex | Q45248493 | ||
| NMDA receptor dependent PGC-1alpha up-regulation protects the cortical neuron against oxygen-glucose deprivation/reperfusion injury | Q46063105 | ||
| Deliberate overfeeding in women and men: energy cost and composition of the weight gain | Q47207461 | ||
| Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change | Q47244308 | ||
| Distribution of orexin receptor mRNA in the rat brain | Q48347303 | ||
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 357-364 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Reviews in Endocrine and Metabolic Disorders | Q15766899 |
| P1476 | title | Orexin: pathways to obesity resistance? | |
| P478 | volume | 14 |
| Q38946106 | Estrogenic suppression of binge-like eating elicited by cyclic food restriction and frustrative-nonreward stress in female rats |
| Q33693961 | Mechanisms of body weight fluctuations in Parkinson's disease |
| Q52664453 | Microglial Immune Response to Low Concentrations of Combustion-Generated Nanoparticles: An In Vitro Model of Brain Health. |
| Q37139426 | Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. |
| Q28397766 | Obesity Resistance Promotes Mild Contractile Dysfunction Associated with Intracellular Ca2+ Handling |
| Q41493386 | Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism. |
| Q38756276 | Orexin A attenuates palmitic acid-induced hypothalamic cell death |
| Q47436045 | Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice |
| Q39623518 | Role of orexin A signaling in dietary palmitic acid-activated microglial cells |
| Q34451399 | Sleep disorders, obesity, and aging: the role of orexin |
Search more.